Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data - Top-Institutions - MDSpire

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

  • By

  • Mohammed Salah Salem

  • Yola Moride

  • Bernard Bégaud

  • July 13, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Health
    NYU Langone Health

    New York, New York

    Key Differentiators

    • Cardiology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology

Original Source(s)

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

  • by Mohammed Salah Salem, Yola Moride, Bernard Bégaud

  • July 13, 2026

Related Content

Association between obstructive sleep apnea syndrome and blood pressure variability: a meta-analysis

Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease

Nontraditional lipid and lipid-inflammatory parameters for risk stratification of abnormal glucose metabolism: a cross-sectional study in Chinese adults